Biological Seed Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Microbials, Botanicals & Others), By Crop (Corn, Wheat, Soybean, Cotton, Sunflower, Vegetable Crops, Other Crops), By Treatment Method (Seed Coating, Seed Dressing and Seed Pelleting), By Function (Seed Enhancement and Seed Protection), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 1.68 Billion
CAGR (2026-2031)	8.95%
Fastest Growing Segment	Microbials
Largest Market	North America
Market Size (2031)	USD 2.81 Billion

Market Overview

The Global Biological Seed Treatment Market will grow from USD 1.68 Billion in 2025 to USD 2.81 Billion by 2031 at a 8.95% CAGR. Biological seed treatments are agricultural inputs derived from natural materials, such as beneficial microorganisms, plant extracts, and fermentation byproducts, applied directly to seeds to suppress pests and diseases or enhance plant vigor. The primary drivers supporting this market include stringent regulatory frameworks reducing reliance on synthetic agrochemicals and the critical need for resistance management strategies in conventional farming. Furthermore, the global imperative for sustainable agricultural practices encourages the adoption of these solutions, as they offer lower environmental residue levels and improved compatibility with soil health initiatives.

Despite this momentum, a significant challenge impeding broader market expansion is the inconsistent performance and limited shelf stability of biological formulations under varying environmental conditions compared to synthetic alternatives. Highlighting the sector's rapid development, according to CropLife Brasil, in the 2024/2025 crop cycle, the adoption of bioinputs in Brazil grew by 13%, illustrating the accelerating integration of biological technologies into major agricultural economies.

Key Market Drivers

The implementation of stringent regulations restricting synthetic chemical pesticides serves as a primary catalyst for the Global Biological Seed Treatment Market. Governments worldwide are aggressively lowering Maximum Residue Limits (MRLs) and phasing out conventional active ingredients, compelling growers to integrate biological alternatives that offer favorable safety profiles and regulatory compliance. This legislative pressure is directly converting crop protection strategies from chemical-first to biological-inclusive approaches, particularly in export-oriented regions where residue standards are most rigorous. Consequently, major agribusinesses are witnessing distinct growth in their biological portfolios even amidst broader sector challenges. For instance, according to Syngenta Group, March 2025, in the 'Full Year and Fourth Quarter 2024 Financial Results', the company's biologicals business sustained robust growth momentum throughout the year, defying a broader 13% sales decline in the overall crop protection segment.

Simultaneously, the increasing global adoption of organic and regenerative farming practices is fundamentally reshaping the demand for seed-applied biologicals. These practices prioritize soil health restoration, necessitating seed treatments that introduce beneficial microbes directly into the rhizosphere at planting to enhance nutrient uptake and soil structure. This trend is driving significant industrial investment in platforms that support these agronomic systems. According to Bayer, November 2024, in the '2024 Crop Science Sustainability Progress Report', the company expanded its ForGround regenerative agriculture program to growers in 28 U.S. states, extending enrollment possibilities to 12 different cash crops. The tangible market impact of these sustainable shifts is evident in recent regional volume expansions. According to Corteva Agriscience, February 2025, in the 'Fourth Quarter and Full-Year 2024 Results', Crop Protection volumes increased by 16% in the fourth quarter, driven significantly by the demand for biologicals and new technologies in Latin America.

Download Free Sample Report

Key Market Challenges

The inconsistent performance and limited shelf stability of biological formulations constitute a primary obstacle hindering the scalability of the Global Biological Seed Treatment Market. Unlike synthetic agrochemicals which offer extended storage viability and consistent efficacy across diverse field conditions, biological inputs frequently contain living organisms that are highly sensitive to environmental variables such as temperature fluctuations and humidity. When these treatments degrade during the supply chain or fail to establish properly in the soil, farmers face increased financial risk and uncertain yield outcomes. This volatility compels agricultural producers to prioritize the predictability of chemical alternatives, effectively capping the conversion rate from conventional inputs to biological solutions.

This hesitation significantly restricts the market share of biological products relative to the wider agricultural inputs sector. The logistical complexity required to maintain product viability reduces distributor confidence and limits shelf space for these treatments. Highlighting this disparity, according to the International Biocontrol Manufacturers Association, in 2024, the European biocontrol market was valued at 1.6 billion Euros, representing approximately 10% of the total crop protection market. This statistic demonstrates that despite regulatory support, the technical limitations regarding stability and reliability prevent biologicals from challenging the dominance of synthetic products, thereby directly impeding broader market growth.

Key Market Trends

The increasing commercialization of bio-nematicides for seed-applied nematode control is rapidly gaining traction as a viable alternative to conventional soil fumigants. Unlike early biological options which were often restricted to high-value horticultural crops, modern bio-nematicide formulations are delivering efficacy comparable to synthetic standards in broad-acre agriculture, effectively addressing the critical issue of nematode resistance management. This shift toward large-scale adoption in major staple crops is substantiated by recent deployment data. According to Albaugh, October 2025, in the 'Albaugh Introduces BIOST 2G Nematicide + Insecticide to U.S. Seed Treatment Market' press release, the company’s novel biological active ingredient has successfully expanded its footprint, being utilized across more than 20 million acres of row crops.

Strategic acquisitions of biological pure-players by major agrochemical conglomerates are further consolidating the sector, enabling the industrial scaling of niche technologies. By integrating specialized startups into established global supply chains, multinational corporations are overcoming historical barriers related to distribution logistics and formulation stability, thereby ensuring these sensitive inputs reach a wider market with maintained viability. This consolidation strategy is directly translating into substantial volume expansion for integrated biological portfolios. According to Corteva Agriscience, November 2025, in the 'Third Quarter and Year-To-Date 2025 Results', the company reported double-digit volume growth in its biologicals and new product segments, confirming the successful commercial scaling of its acquired biological assets.

Segmental Insights

The Microbials segment represents the fastest-growing category within the Global Biological Seed Treatment Market, driven primarily by intensifying regulatory pressure against synthetic agrochemicals. Authorities such as the United States Environmental Protection Agency and the European Commission have implemented stricter controls on chemical residues, necessitating a shift toward safer biological alternatives. Consequently, agricultural producers are increasingly adopting microbial inoculants because they naturally enhance nutrient availability and strengthen root development without leaving harmful environmental traces. This transition is further supported by the rising demand for sustainable solutions that maintain high crop yields while strictly adhering to safety standards regarding soil health.

Regional Insights

North America leads the Global Biological Seed Treatment Market, driven by the extensive adoption of modern agricultural technologies and a growing preference for sustainable farming practices. This dominance is reinforced by the robust presence of key industry players who invest heavily in developing effective bio-based formulations. Additionally, the region benefits from a structured regulatory environment that supports innovation; for example, the United States Environmental Protection Agency (EPA) provides established guidelines for the registration of biological agents. These factors collectively foster a favorable landscape for the expansion of biological seed treatments across the continent.

Recent Developments

• In October 2025, Albaugh announced that it had received end-use registration from the U.S. Environmental Protection Agency for a new biological seed treatment named BIOST 2G Nematicide + Insecticide. This product represents the company’s second-generation biological technology and features a novel active ingredient designed to protect crops against plant-parasitic nematodes and soil-borne insect pests such as corn rootworm larvae. The company stated that the formulation is a non-living, shelf-stable biopesticide intended to minimize crop losses while maintaining an environmentally compatible profile. Albaugh planned to make the product commercially available for crops including corn, soybeans, and cotton starting in the fall of 2025.
• In January 2025, DPH Biologicals entered into a strategic partnership with Aginnovation to distribute advanced biological seed enhancement solutions across North America. Under this agreement, Aginnovation was named the exclusive distributor of DPH Biologicals' flagship bio-fungicide seed treatment, Companion Maxx ST, for the vegetable and specialty crop markets. The collaboration aimed to leverage Aginnovation’s specialized technologies to deliver biological products that improve seed health and crop performance. The companies highlighted that this alliance would support environmental stewardship by offering growers sustainable tools that integrate seamlessly into modern farming practices, with commercial availability expected immediately in 2025.
• In November 2024, Lavie Bio announced the commercial expansion of its bio-inoculant seed treatment, Yalos, to include soybeans following successful field trials in the United States. The company reported that the product, which was already available for wheat and barley, demonstrated an average yield increase of more than 5% in soybean crops during the 2024 trials. Yalos utilizes two novel microbes to enhance early plant vigor, biomass, and nutrient availability. Lavie Bio stated its intention to make the treatment commercially available for the 2025 spring season, significantly increasing the potential market reach of the product within the North American agricultural sector.
• In April 2024, Certis Biologicals and Certis Belchim announced the launch of Toltek, a new bio-fungicide formulation specifically developed for cereal seed treatment. The companies described the product as the first biological fungicide registered in Europe to control Take-All disease in wheat and barley. Toltek contains the microorganism Bacillus amyloliquefaciens D747, a strain proven to protect against the soil-borne pathogen Gaeumannomyces tritici. The co-development project, which spanned five years, resulted in a solution compatible with industrial seed treatment requirements. The product received its initial authorization in France, with further registrations anticipated across other European countries.

Key Market Players

• Bayer AG
• Syngenta AG
• BASF SE
• Monsanto Company
• Italpollina S.p.A.
• Koppert Biological Systems
• Plant Health Care plc
• Precision Laboratories, LLC
• Verdesian Life Sciences
• Valent Biosciences LLC

By Type	By Crop	By Treatment Method	By Function	By Region
Microbials Botanicals & Others	Corn Wheat Soybean Cotton Sunflower Vegetable Crops Other Crops	Seed Coating Seed Dressing Seed Pelleting	Seed Enhancement Seed Protection	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Biological Seed Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Biological Seed Treatment Market, By Type:

• Microbials
• Botanicals & Others

• Biological Seed Treatment Market, By Crop:

• Corn
• Wheat
• Soybean
• Cotton
• Sunflower
• Vegetable Crops
• Other Crops

• Biological Seed Treatment Market, By Treatment Method:

• Seed Coating
• Seed Dressing
• Seed Pelleting

• Biological Seed Treatment Market, By Function:

• Seed Enhancement
• Seed Protection

• Biological Seed Treatment Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE